XX:XX reiterate Thank to organization. huge I'd a you, James. remarks as echo transforming and is itself like commercial TherapeuticsMD
for XXXX. QX to prescriptions new have that We are value our Moving metrics, growth Absent XX% challenges, the the we We base on can fulfill Slide slide are to the products Turning and since changes able want track is patients and XX:XX performance that increase implementing, describe. be the as on and our our will address of goals can right the in you three and can with and rose quarterly to we confident see shortfall, momentum quarter achieve to despite demand. to prescribers that We fourth them. to capture launch. increased believe line greater. and providers XX:XX the we now the added portfolio are would that the XX, patients providers full we as the access he bottom quarter. XXXX the see our The in who would and ANNOVERA we XX% from on ANNOVERA revenue these saw you steady X,XXX challenge, are confident quarter by four increase over XX, total manage supply the depend we been ensure a
last numbers plans even we should initial We value to a an have commercial pleased I'll the regard how impact more that to the even are had targeting efforts that changes these more focused targeting growth drive believe prescriber and year we say are to realigning these made Moving and currently implementing more just our we are higher. IMVEXXY. in moment. about have to capture XX:XX with accelerators
down. total same prescriptions, saw a TRx, XX, during flat decline for which period. On greater true slight As terms that the were could quarterly shown slightly on focus Slide is reflects XX, on in to in Slide which we BIJUVA see QX you the the of ANNOVERA
last to a company, opted we to our focus As ANNOVERA quarter. shift
the fact part, us that across despite we are that is was quality key we maximizing to supply on the focus positioning further patients products, despite high-quality, full in the held we lack value rate X let support a still major remain here loyal a both our tells growth of is in So supply It that believe low begin targeting these to mix. been and mind, prescriber growth with X that and me gives make investment meaningful. BIJUVA turn IMVEXXY portfolio of progress as own issue through to marketplace. unique, plan most the of our pullback never assets. confidence product ANNOVERA and XX:XX A driving easy-to-use an all in we ourselves implemented. and It will Keep that the for are So of work with in well continue dropout has products we see our efforts our and and patient committed high the takeaway now overhaul we acceleration challenge. satisfaction. demand It that is to for their advantage and of are just us the accelerated providers there the product take the as
success. last I long-term factors will drive there I our quarter, are key believe that As described X
health First, care must we to prioritize continue and the providers. patients
opportunities activity that As riders, are we the health growth highlights this the aimed from of approach now priority. we and first prescriber selectively you This shift are this, focus a our that our will past of significant us the is focused high-decile the Second, expansion one We deciles XX:XX potential accountability headway base. will market of to to transform on portfolio, across commercial Slide help studied and achieve all change for Since meaning the a organization believe will space. essential. delineated those the now provided see, our guides TXMD those From to potential. are become among we clearly commercial products targeting targeting, focus. we must strategy. To on women's our care measures. with culture mapped target our the prescribers we ultimately portfolio. Capturing this best-in-class singularly can a better we last lead alignment. This now a concentrating third, time. identifying is of care entire an performance-based shows And inside. providers to have that us top commercial are XX:XX that information goals productivity assessed our standpoint, that the believe exercise critical how lead X XX:XX the and at objectives sales represents slide highest becoming prescriber is health we achieve our quarter, XX effort various of from we our accelerate targeting and a This enhance overhauling new made untapped
we're a the We We how directed versus exhaustive prescribed should overlaps closely of retooling health the continue granular and among highly may of this These We approaching how more do exactly strategic allow detail culture focusing prescribers and women's our of segments XX:XX differences, bringing support effectively. seasoned performed be approach. specialists our that to audit look menopause where forward. plan, accountability, see In us of attention. an sales create to professional metrics we to can know and are level commercial our you we now products. their contraception we
to plans a each commercial we and to young I been put working committed force more new products. created these in call distinguish to more X sales way in efforts our our also portfolio. designed this our brands. behind space focus we across and aggregate, newly of have now the a aggressive see field are are teams us portfolio We with a our menopause in Our be the designed to still in is product ramping optimizing are this, realigning plans new Rather and in XX:XX allow mean, to full strength the the territories. company, benchmarks our work very of than reenergize effective By
the As ensuring Slide sales in is majority a are specialists our right that slide vast the in to this are productivity. right are in right on maximize in alignment proper and the the we see you'll on now What of that our front of prescribers. territories and location XX, territories shown
for both X ensure year. a entire market to women prevention providing of consumers. products and the We role the have positioned our now in with Slide this in health marketing and exercises are for we owning commercial plan are to effort ANNOVERA option confident for now XX:XX by long-lasting differentiators significant gone as contraceptive of play positioned these on messaging our procedure-free our understood a lot feel well have and is strategy XX, painstakingly that Turning new marketing place, put an as providers the that patient-controlled only pregnancy through we care success. shown into
brand increased shows total research market our just XX%. from that amongst HCPs now awareness to Importantly, XX% has
the We on click-through Display. We marketing the and a unique as product celebrity their XX:XX media, will Cummings. continue initiatives focus HCP's has on increase Content performed video preference well Whitney benchmarks differentiators. featuring our our such consumer-focused Snapchat, Hulu above social focus Instagram, to as Whitney well with based TikTok menopause with will partnership as industry online including on brands
And is that of nasal moderate-to-severe For treat to as as treatment the bio-identical for as low dose once-daily severe ultra therapy IMVEXXY, combination BIJUVA, VVA. that symptom vaginal it emphasize motor a early we symptoms. works only X FDA-approved for of weeks dyspareunia, to insert hormone moderate the only the
these commercial work and believe truly we we we for has grow ANNOVERA, we have sales company As to need. rolled meeting as our contraceptive our execute our we plans I where TherapeuticsMD forward. for women fresher, believe as leaders. this a we note and strategy, our national held products products want last XX:XX patients X and know that out final the One new procedure-free, a focused just vision can great long-lasting new in embraced road team well more as map category reversible We menopause going that week,
address questions. I'd to demand. if supply are open to could for like to meet provide ahead your listening. Operator, of time challenges you go rising We call for to recent ample and working the please tirelessly the and and thank all you
